BLTE Belite Bio, Inc - American Depositary Shares
NASDAQ · Pharmaceuticals · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Mar 31, 2026
$159,56
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$75,95rendah 52m
$198,58tinggi 52m
Kapitalisasi Pasar
$6.28B
P/E
-69.1
EPS
$-2.31
lencana Anda
Rentang 52M
$76–$199
Peringkat Analis
BUY
Target Harga
$229
P/E
-69.1
ROE
-16.9%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
BLTE Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$159.56
Kapitalisasi Pasar
$6.28B
P/E
-69.1
EPS
$-2.31
ROE
-16.9%
Rentang 52M
$76–$199
BLTE Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
EPS$-2.312020-12-31 → 2025-12-31
Arus Kas Bebas$-37M2022-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | BLTE | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -69.1rata-rata 5T ≈-52.3 | ≈-52.3 | · | · | |
| P/B | 8.1rata-rata 5T ≈13.7 | ≈13.7 | 7.5 | Nilai wajar | |
| Price / FCF (Harga / FCF) | -169.4rata-rata 5T ≈-86.5 | ≈-86.5 | · | · | |
| Price / Cash Flow (Harga / Arus Kas) | -169.7rata-rata 5T ≈-87.3 | ≈-87.3 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 8.1rata-rata 5T ≈13.7 | ≈13.7 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | BLTE | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -16.6%rata-rata 5T ≈-33.0% | ≈-33.0% | -9.2% | Di bawah rata-rata | |
| ROE | -16.9%rata-rata 5T ≈-47.8% | ≈-47.8% | -10.2% | Di bawah rata-rata | |
| ROIC | -10.9%rata-rata 5T ≈-24.5% | ≈-24.5% | -3.9% | Di bawah rata-rata |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | BLTE | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Current Ratio (Rasio Lancar) | 50.0rata-rata 5T ≈29.9 | ≈29.9 | 4.9 | Likuiditas kuat | |
| Quick Ratio (Rasio Cepat) | 35.7rata-rata 5T ≈21.3 | ≈21.3 | 2.5 | Likuiditas kuat |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-14.0%
Laporan Berikutnya
Nov 09, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 13, 2026 | $-0.70 | $-0.80 | 13.0% |
| 31 Maret 2026 | Mei 20, 2026 | $-0.68 | $-0.65 | -4.9% |
| 31 Des. 2025 | $-0.70 | $-0.56 | -25.6% | |
| 30 Sep. 2025 | $-0.65 | $-0.50 | -30.7% | |
| 30 Juni 2025 | $-0.50 | $-0.43 | -17.4% | |
| 31 Maret 2025 | $-0.45 | $-0.38 | -18.1% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $45M | $30M | $25M | $9M | $7M | |
| SG&A Expense | $39M | $10M | $7M | $4M | $2M | |
| Operating Expenses | $84M | $40M | $32M | $13M | $10M | |
| Operating Income | $-84M | $-40M | $-32M | $-13M | $-10M | |
| Interest Expense | · | · | $25.0K | $16.0K | · | |
| Interest Income | $7M | $4M | $74.0K | $23.0K | $5.0K | |
| Other Non-op | $-41.0K | $141.0K | $-4.0K | $166.0K | $126.0K | |
| Pretax Income | $-78M | $-36M | $-32M | $-13M | $-10M | |
| Income Tax | $0 | $6.0K | $9.0K | · | · | |
| Net Income | $-78M | $-36M | $-32M | $-13M | $-10M | |
| EPS (Basic) | $-2.31 | $-1.18 | $-1.19 | $-0.63 | $-1.01 | |
| EPS (Diluted) | $-2.31 | $-1.18 | $-1.19 | $-0.63 | $-1.01 | |
| Shares (Basic) | 33,538,160 | 30,538,378 | 26,593,673 | 19,976,596 | 9,569,932 | |
| Shares (Diluted) | 33,538,160 | 30,538,378 | 26,593,673 | 19,976,596 | 9,569,932 | |
| EBITDA | $-84M | $-40M | $-32M | $-13M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $353M | $32M | $88M | $42M | $17M | |
| Prepaid Expense | $1M | $1M | $947.0K | $716.0K | $87.0K | |
| Other Current Assets | $5.0K | · | · | · | · | |
| Current Assets | $494M | $147M | $90M | $43M | $17M | |
| PP&E (Net) | $344.0K | $444.0K | $490.0K | $541.0K | $94.0K | |
| Accum. Depreciation | $507.0K | $341.0K | $183.0K | $91.0K | $47.0K | |
| Intangibles | $19.0K | $31.0K | · | · | · | |
| Total Assets | $781M | $152M | $95M | $44M | $18M | |
| Accrued Liabilities | $10M | $6M | $3M | $2M | $2M | |
| Current Liabilities | $10M | $6M | $4M | $2M | $2M | |
| Capital Leases | $188.0K | $261.0K | $578.0K | $668.0K | · | |
| Total Liabilities | $10M | $6M | $4M | $3M | $2M | |
| Common Stock | $4.0K | $3.0K | $3.0K | $3.0K | $1.0K | |
| Paid-in Capital | $956M | $254M | $162M | $82M | $12M | |
| Retained Earnings | $-185M | $-108M | $-72M | $-40M | $-27M | |
| AOCI | $-536.0K | $-660.0K | $-374.0K | $-392.0K | $-196.0K | |
| Stockholders' Equity | $770M | $146M | $90M | $42M | $-15M | |
| Liabilities + Equity | $781M | $152M | $95M | $44M | $18M | |
| Shares Outstanding | 39,339,960 | 31,826,549 | 29,149,444 | 24,898,908 | 10,274,403 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $39M | $9M | $4M | $1M | $2M | |
| Amort. of Intangibles | $12.0K | $4.0K | · | · | · | |
| Operating Cash Flow | $-37M | $-29M | $-30M | $-11M | $-7M | |
| CapEx | $71.0K | $116.0K | $63.0K | $394.0K | $74.0K | |
| Investing Cash Flow | $-305M | $-111M | $-63.0K | $-394.0K | $-56.0K | |
| Financing Cash Flow | $663M | $84M | $76M | $37M | $-583.0K | |
| Net Change in Cash | $321M | $-56M | $46M | $25M | $-8M | |
| Taxes Paid | · | $6.0K | $9.0K | · | · | |
| Free Cash Flow | $-37M | $-29M | $-30M | $-12M | · | |
| Levered FCF | · | · | $-30M | · | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -16.6% | -29.3% | -45.5% | -40.4% | · | |
| ROE | -16.9% | -30.6% | -47.9% | -95.8% | · | |
| ROIC | -10.9% | -27.4% | -35.0% | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 50.0 | 24.3 | 24.8 | 20.3 | · | |
| Quick Ratio | 35.7 | 5.2 | 24.3 | 20.0 | · | |
| Interest Coverage | · | · | -1266.7 | -801.3 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $19.59 | $4.58 | $3.10 | $1.67 | · | |
| Cash Flow / Share | $-1.10 | $-0.96 | $-1.12 | $-0.57 | · | |
| Cash / Share | $8.97 | $1.00 | $3.02 | $1.69 | · | |
| EPS (TTM) | $-2.31 | $-1.18 | $-1.19 | $-0.63 | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-78M | $-36M | $-32M | $-13M | · | |
| Market Cap | $6.29B | $2.01B | $1.33B | $751M | · | |
| P/E | -69.2 | -53.5 | -38.4 | -47.8 | · | |
| P/B | 8.2 | 13.8 | 14.7 | 18.1 | · | |
| P / Tangible Book | 8.2 | 13.8 | 14.7 | 18.1 | · | |
| P / Cash Flow | -170.1 | -68.7 | -44.7 | -65.5 | · | |
| P / FCF | -169.8 | -68.4 | -44.6 | -63.3 | · | |
| Earnings Yield | -1.4% | -1.9% | -2.6% | -2.1% | · |
Tidak ada pengajuan triwulanan untuk BLTE
Kami belum memiliki pengajuan SEC untuk ticker ini.
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Laba Bersih | $-78M | $-36M | $-32M | $-13M | $-10M |
| EPS Dilusian | $-2.31 | $-1.18 | $-1.19 | $-0.63 | $-1.01 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 50.0 | 24.3 | 24.8 | 20.3 | · |
| Rasio Cepat | 35.7 | 5.2 | 24.3 | 20.0 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-37M | $-29M | $-30M | $-12M | · |
Pemilik institusional (13F) 82 pengaju · $1.4B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
82
Nilai yang dipegang
$1.4B
Posisi baru
22
Posisi yang keluar
14
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 22 (-5 vs Kuartal sebelumnya) | 14 (-8 vs Kuartal sebelumnya) | 27 (+2 vs Kuartal sebelumnya) | 22 (+8 vs Kuartal sebelumnya) | +372K |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Darwin Global Management, Ltd. | $456.588.244 | 3.077.219 | 32,41% | Saham |
| Paradigm Biocapital Advisors LP | $189.844.565 | 1.232.877 | 13,48% | Saham |
| RTW INVESTMENTS, LP | $110.150.398 | 715.332 | 7,82% | Saham |
| MILLENNIUM MANAGEMENT LLC | $76.155.438 | 494.564 | 5,41% | Saham |
| MAVERICK CAPITAL LTD | $61.025.949 | 396.311 | 4,33% | Saham |
| EVENTIDE ASSET MANAGEMENT, LLC | $60.181.804 | 390.829 | 4,27% | Saham |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $55.003.288 | 357.199 | 3,90% | Saham |
| Holocene Advisors, LP | $38.655.624 | 251.035 | 2,74% | Saham |
| Logos Global Management LP | $38.496.250 | 250.000 | 2,73% | Saham |
| MORGAN STANLEY | $36.197.407 | 235.071 | 2,57% | Saham |
| UBS Group AG | $34.644.931 | 224.989 | 2,46% | Saham |
| CITADEL ADVISORS LLC | $28.667.080 | 186.168 | 2,03% | Saham |
| GOLDMAN SACHS GROUP INC | $25.590.459 | 166.188 | 1,82% | Saham |
| Affinity Asset Advisors, LLC | $25.407.525 | 165.000 | 1,80% | Saham |
| MPM BIOIMPACT LLC | $21.127.974 | 137.208 | 1,50% | Saham |
| BANK OF AMERICA CORP /DE/ | $19.214.710 | 124.783 | 1,36% | Saham |
| Patient Square Capital LP | $16.938.350 | 110.000 | 1,20% | Saham |
| JANE STREET GROUP, LLC | $10.132.367 | 65.801 | 0,72% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $8.796.393 | 57.125 | 0,62% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $8.586.666 | 55.763 | 0,61% | Saham |
| Point72 Asset Management, L.P. | $7.881.877 | 51.186 | 0,56% | Saham |
| Soleus Capital Management, L.P. | $7.779.938 | 50.524 | 0,55% | Saham |
| Trexquant Investment LP | $7.624.721 | 49.516 | 0,54% | Saham |
| TWO SIGMA INVESTMENTS, LP | $5.866.829 | 38.100 | 0,42% | Saham |
| PFM Health Sciences, LP | $5.359.140 | 34.803 | 0,38% | Saham |
| JPMORGAN CHASE & CO | $5.131.442 | 33.181 | 0,36% | Saham |
| Walleye Capital LLC | $4.884.558 | 31.721 | 0,35% | Saham |
| Artia Global Partners LP | $3.847.931 | 24.989 | 0,27% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $3.486.220 | 22.640 | 0,25% | Saham |
| BALANCE CAPITAL PARTNERS L.P. | $3.464.663 | 22.500 | 0,25% | Saham |
| NATIONAL BANK OF CANADA /FI/ | $3.079.700 | 20.000 | 0,22% | Saham |
| STATE STREET CORP | $2.452.057 | 15.924 | 0,17% | Saham |
| Verdad Advisers, LP | $2.118.526 | 13.758 | 0,15% | Saham |
| ORBIMED ADVISORS LLC | $2.048.001 | 13.300 | 0,15% | Saham |
| TD Asset Management Inc | $2.003.345 | 13.010 | 0,14% | Saham |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.960.691 | 12.733 | 0,14% | Saham |
| Qube Research & Technologies Ltd | $1.874.151 | 12.171 | 0,13% | Saham |
| Lighthouse Investment Partners, LLC | $1.539.850 | 10.000 | 0,11% | Saham |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1.512.133 | 9.820 | 0,11% | Saham |
| HighVista Strategies LLC | $1.471.173 | 9.554 | 0,10% | Saham |
| Squarepoint Ops LLC | $1.352.758 | 8.785 | 0,10% | Saham |
| BARCLAYS PLC | $1.050.486 | 6.822 | 0,07% | Saham |
| Capricorn Fund Managers Ltd | $985.504 | 6.400 | 0,07% | Saham |
| Voleon Capital Management LP | $968.412 | 6.289 | 0,07% | Saham |
| SmartHarvest Portfolios, LLC | $671.221 | 4.359 | 0,05% | Saham |
| XTX Topco Ltd | $667.217 | 4.333 | 0,05% | Saham |
| Mariner, LLC | $590.533 | 3.835 | 0,04% | Saham |
| Entropy Technologies, LP | $569.745 | 3.700 | 0,04% | Saham |
| High Net Worth Advisory Group LLC | $538.948 | 3.500 | 0,04% | Saham |
| FMR LLC | $477.354 | 3.100 | 0,03% | Saham |
Orang dalam perusahaan 5 orang dalam · 4 pejabat · 3 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Yu-Hsin Lin | Chief Executive Officer | 8 Sep. 2026 S | 70.134 | 0 | 25 | $-20.817.711 |
| Hao-Yuan Chuang | Chief Financial Officer | 8 Sep. 2026 S | 26.038 | 0 | 25 | $-13.994.952 |
| Hendrik Peter Scholl | Chief Medical Officer | 18 Juni 2026 S | 15.000 | 0 | 13 | $-2.858.130 |
| Nathan L. Mata | Chief Scientific Officer | 7 Mei 2026 S | 0 | 0 | 103 | $-2.673.521 |
| Wan-Shan Chen | Direktur | 9 April 2026 S | 9.096 | 0 | 1 | $-198.473 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 1 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,77% | 2.250 NS | 31 Juli 2026 | N-PORT |
BLTE Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 14 analis
BELI
Target median
$217.00
+36,0%
4 28,6%
Beli Kuat
9 64,3%
Beli
1 7,1%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
9 analis · 2026-10-03Target rata-rata $228.89 +43,5%
← Di bawah semua target
Harga saat ini $159.56
Rendah$185.00
Rata-rata$228.89
Tinggi$303.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| BLTE | $6.29B | -69.2 | · | · | -16.9% | · |
| CORT | $3.69B | 42.4 | 12.8% | 13.1% | 15.5% | · |
| ELAN | $11.25B | -48.1 | 6.2% | -4.9% | -3.5% | 55.0% |
| AXSM | $9.29B | -49.6 | 65.5% | -28.7% | -227.0% | · |
| AMRX | · | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| LGND | $3.74B | 30.8 | 60.4% | 46.4% | 13.5% | · |
| DFTX | $1.32B | -6.5 | 212.0% | · | -71.0% | · |
| MANE | · | · | · | · | 82.6% | · |
| EWTX | $2.64B | -15.2 | · | · | -30.2% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 20-F diajukan Mar 31, 2026